ArticleMolecular genetics and metabolism reports2024
Combining angiotensin receptor blockade and enzyme replacement therapy for vascular disease in mucopolysaccharidosis type I.
Sarah C Hurt et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.